Comprehensive analysis of PTEN status in breast carcinomas-Reference-Cited by-同舟云学术

Comprehensive analysis of PTEN status in breast carcinomas

Published:2013-02-12 Issue:2 Volume:133 Page:323-334
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Jones Natalie¹,Bonnet Françoise,Sfar Sana²,Lafitte Marie¹,Lafon Delfine²,Sierankowski Ghislaine³,Brouste Véronique⁴,Banneau Guillaume¹,Tunon de Lara Christine⁵,Debled Marc⁶,MacGrogan Gaëtan,Longy Michel,Sevenet Nicolas

Affiliation:

1. INSERM U916 VINCO; University of Bordeaux; Institut Bergonié; Bordeaux; France

2. Cancer Genetics Unit; Institut Bergonié; Bordeaux; France

3. Department of Pathology; Institut Bergonié; Bordeaux; France

4. Clinical & Epidemiological Research Unit; Institut Bergonié; Bordeaux; France

5. Department of Surgery; Institut Bergonié; Bordeaux; France

6. Department of Medical Oncology; Institut Bergonié; Bordeaux; France

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. HER-2 testing in breast cancer using parallel tissue-based methods;Yaziji;JAMA,2004

2. Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing;Pathmanathan;Breast

3. PI3K pathway alterations in cancer: variations on a theme;Yuan;Oncogene,2008

4. Mutation of the PIK3CA gene in ovarian and breast cancer;Campbell;Cancer Res,2004

5. Somatic mutation and gain of copy number of PIK3CA in human breast cancer;Wu;Breast Cancer Res,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes;Human Pathology;2024-04

2. Endogenous PTEN acts as the key determinant for mTOR inhibitor sensitivity by inducing the stress-sensitized PTEN-mediated death axis in KSHV-associated malignant cells;Frontiers in Molecular Biosciences;2023-08-02

3. New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer;Diagnostics;2023-06-02

4. PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification;Modern Pathology;2023-05

5. PTEN mutations prevalence in HER2-positive breast cancer patients;Revista de Senología y Patología Mamaria;2023-01